eQcell

Guelph, Canada Founded: 2010 • Age: 16 yrs
Stem cell therapies for animal health are developed.

About eQcell

eQcell is a company based in Guelph (Canada) founded in 2010.. eQcell has raised $4.6 million across 3 funding rounds from investors including Ag Capital Canada and Accelerator Centre. The company has 8 employees as of December 31, 2024. eQcell offers products and services including Equine Cord Blood Stem Cells and Canine Adipose-Derived Mesenchymal Stromal Cells. eQcell operates in a competitive market with competitors including Gallant, Bioceltix, Nupsala, J-ARM and Vetherapy, among others.

  • Headquarter Guelph, Canada
  • Employees 8 as on 31 Dec, 2024
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Eqcell Inc.
Operational Areas
Healthcare → Veterinary & Animal Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4.6 M (USD)

    in 3 rounds

  • Latest Funding Round
    $855.54 K (USD), Series A

    Aug 04, 2022

  • Investors
  • Employee Count
    8

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of eQcell

eQcell offers a comprehensive portfolio of products and services, including Equine Cord Blood Stem Cells and Canine Adipose-Derived Mesenchymal Stromal Cells. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides off-the-shelf treatments for equine conditions using allogeneic cells.

Offers therapeutics for canine diseases via adipose-derived stem cells.

Funding Insights of eQcell

eQcell has successfully raised a total of $4.6M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $855.54 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $855,543
  • First Round

    (29 Apr 2020)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2022 Amount Series A - eQcell Valuation Ag Capital Canada
Dec, 2021 Amount Series A - eQcell Valuation

investors

Apr, 2020 Amount Seed - eQcell Valuation Accelerator Centre
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in eQcell

eQcell has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Ag Capital Canada and Accelerator Centre. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Capital and support are provided for agricultural business growth.
Founded Year Domain Location
Startups are built and accelerated in a structured studio environment.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by eQcell

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - eQcell

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Eqcell Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of eQcell

eQcell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gallant, Bioceltix, Nupsala, J-ARM and Vetherapy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Stem cell storage for canine regenerative therapy is offered.
domain founded_year HQ Location
Developer of drugs for veterinary therapy
domain founded_year HQ Location
Veterinary pharmaceuticals and products are supplied alongside educational resources.
domain founded_year HQ Location
Developer of lymphocyte therapy and stem cell therapy for dogs and cats
domain founded_year HQ Location
Provider of stem cell therapies for pets
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Eqcell

Frequently Asked Questions about eQcell

When was eQcell founded?

eQcell was founded in 2010 and raised its 1st funding round 10 years after it was founded.

Where is eQcell located?

eQcell is headquartered in Guelph, Canada. It is registered at Guelph, Ontario, Canada.

Is eQcell a funded company?

eQcell is a funded company, having raised a total of $4.6M across 3 funding rounds to date. The company's 1st funding round was a Seed of $30K, raised on Apr 29, 2020.

How many employees does eQcell have?

As of Dec 31, 2024, the latest employee count at eQcell is 8.

What does eQcell do?

The company was founded in 2010 and is based in Guelph, Canada. Operations focus on the biotechnology sector, with emphasis on animal health. Allogeneic equine cord blood stem cells and canine adipose-derived mesenchymal stem cells are developed to offer therapeutic options. These advancements address treatments for veterinary conditions in equine and canine species.

Who are the top competitors of eQcell?

eQcell's top competitors include Gallant, Bioceltix and Vetbiobank.

What products or services does eQcell offer?

eQcell offers Equine Cord Blood Stem Cells and Canine Adipose-Derived Mesenchymal Stromal Cells.

Who are eQcell's investors?

eQcell has 2 investors. Key investors include Ag Capital Canada, and Accelerator Centre.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available